GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Senores Pharmaceuticals Ltd
Senores Pharmaceuticals Board Approves Q1 FY27 Unaudited Financial Results
BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 27 Jul 2026, 03:21 PM IST  ·  BSE ID: 7b7b63d0-b0b7-48e7-ab63-1b213435715a
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board of directors reviewed and approved the latest financial report for the first quarter of the fiscal year.
🤖 AI Summary
  • Senores Pharmaceuticals board approved Q1 FY27 unaudited financial results on July 27, 2026.
  • Statutory auditors issued limited review reports on consolidated and standalone results.
  • Management commentary on Small & Medium Personalities (SMPs) was discussed.
  • Disclosure made as per SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
🏢 How This Affects the Company
💰
Financial Impact
The approval of quarterly financial results is a routine disclosure that provides an update on the company's financial performance for the period.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this board meeting outcome.
👤
Who Is Affected
All shareholders are informed of the company's Q1 FY27 unaudited financial performance and the auditors' review.
🔍
Management Signal
Management is adhering to regulatory requirements by promptly disclosing financial results and auditor reports.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q2 FY27 financial results disclosure
Annual General Meeting agenda
Updates on any new product launches or market expansions
LOW RISK Filing is a routine quarterly financial results disclosure without new material financial data.
💡 Investor Takeaway
Senores Pharmaceuticals board met and approved unaudited consolidated and standalone financial results for the quarter ended June 30, 2026. Auditors' limited review reports are enclosed.
❓ Frequently Asked Questions
When did Senores Pharmaceuticals board approve the Q1 FY27 financial results?
The Board of Directors of Senores Pharmaceuticals approved the unaudited financial results for the quarter ended June 30, 2026, on July 27, 2026.
Did auditors review Senores Pharmaceuticals Q1 FY27 financial results?
Yes, M/s. Pankaj R. Shah and Associates, Chartered Accountants, issued their Limited Review Reports on the unaudited consolidated and standalone financial results.
What SEBI regulations were followed for the Senores Pharmaceuticals board meeting?
The disclosures were made in compliance with Regulations 30, 33, and 47 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.